Literature DB >> 15521261

Higher order aberrations with aspheric ablations using the Nidek EC-5000 CX II laser.

Ian Y L Yeung1, Sanjay Mantry, Ian A Cunliffe, Mark T Benson, Sunil Shah.   

Abstract

PURPOSE: To analyze the change in higher order aberrations in myopic and myopic astigmatic eyes following an aspheric ablation profile for laser in situ keratomileusis (LASIK) using a Nidek EC-5000 CX II excimer laser system.
METHODS: We performed a retrospective audit of 38 eyes (19 patients) with myopia and myopic astigmatism. A customized aspheric transition zone profile (CATz) was used in all eyes (profile 4) with an ablation zone of 5 mm and a transition zone of 9 mm using FinalFit software and a Nidek EC-5000 CX II excimer laser system.
RESULTS: Mean higher order aberrations (RMS) increased from 0.42 microm at baseline to 0.57 microm at 6-month follow-up. Mean spherical aberrations (Z12) increased from 0.02 microm at baseline to 0.33 microm after LASIK. Mean spherical aberration defocus equivalent (DEQ) increased from 0.56 microm at baseline to 1.54 at 6 months after surgery. Mean trefoil (Z6) was -0.11 microm at baseline and -0.14 microm at the 3-month examination. Mean coma (Z7) was -0.09 microm at baseline and -0.10 microm after surgery. Mean coma (Z8) was -0.03 at baseline and 0 at the 3-month examination. Mean trefoil (Z9) was -0.03 at baseline and -0.12 at the 3-month examination.
CONCLUSION: The amount of postoperative higher order aberrations in these myopic eyes was acceptable. However, the clinical significance of these numerical changes in aberrations is not known.

Entities:  

Mesh:

Year:  2004        PMID: 15521261     DOI: 10.3928/1081-597X-20040903-04

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  1 in total

1.  Topographically guided LASIK for myopia using the Nidek CXII customized aspheric treatment zone (CATz).

Authors:  George Waring; Paul J Dougherty; Arturo Chayet; Jeffery Fischer; Barbara Fant; Gary Stevens; Harkaran S Bains
Journal:  Trans Am Ophthalmol Soc       Date:  2007
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.